Amferia kills bacteria logo — Amferia kills bacteria, even resistant bacteria, without har...

Amferia kills bacteria

Amferia kills bacteria, even resistant bacteria, without harming the body

Founded 2018 Sweden Sweden 13 employees Seed Total: $21.60M Biotechnology, Manufacturing +1

General Information

Company Name Amferia kills bacteria
Founded Year 2018
Location Sweden Sweden
Founders / Decision Makers
Team member
Employees 13
Industries Biotechnology, Manufacturing, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Amferia kills bacteria. To contact Amferia kills bacteria, visit amferia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Amferia kills bacteria

Amferia is a Swedish biotechnology startup, founded in 2018, that focuses on developing and marketing innovative medical devices with a strong emphasis on antibacterial products. The company's core objective is to create materials that can effectively eradicate bacteria, including resistant strains, without causing harm to the body. A spin-off from research conducted at Chalmers University of Technology, Amferia is spearheaded by Dr. Anand Kumar Rajasekharan, Professor Martin Andersson, and Dr. Saba Atefyekta. The company recently secured a kr15.40M Seed Round investment on 27 January 2023, with key contributions from Almi Invest and Chalmers Ventures. Amferia's pioneering approach to combating bacteria without posing risks to the human body positions it as a promising player in the biotechnology and manufacturing sectors.

Taxonomy: antibacterial products, wound care, biomedical materials, bacteria, resistant bacteria, Chalmers University of Technology, Swedish company

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round kr15.40M 2
Almi Invest, Chalmers Ventures
27 Jan 2023
Seed Round kr6.20M 4
Almi Invest, Chalmers Ventures +2
22 Jan 2020

Amferia kills bacteria Alternatives & Competitors

View All Alternatives
Amferia kills bacteria vs
RedDress Ltd.
RedDress Ltd. United States

Healing is in Our Blood

Series D
40 employees
Biotechnology, Health Care
Amferia kills bacteria vs
Reapplix
Reapplix Denmark

Every wound is personal

Series A
29 employees
Biotechnology, Health and Wellness
Amferia kills bacteria vs
SANUWAVE
SANUWAVE United States

Heal Wounds With Energy First

Post-IPO Equity
54 employees
Biotechnology, Health Care

FAQ About Amferia kills bacteria

Amferia kills bacteria, even resistant bacteria, without harming the body
Amferia kills bacteria was founded in 2018.
Amferia kills bacteria is headquartered in Sweden.
Amferia kills bacteria operates in Biotechnology, Manufacturing and Medical Devices. Its work centres on antibacterial products, wound care, biomedical materials and bacteria.
Amferia kills bacteria has approximately 13 employees.
Amferia kills bacteria has completed 2 funding rounds, raising a total of $21.60M. The latest funding stage is Seed.
Top alternatives and competitors to Amferia kills bacteria include RedDress Ltd., Reapplix, SANUWAVE, Parx Materials, MGB Biopharma Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amferia kills bacteria and RedDress Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amferia kills bacteria, https://bouncewatch.com/company/amferia, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes